-
About ovarian cancer
- What is ovarian cancer?
- Ovarian cancer risk
- Genetic and genomic testing
- Symptoms
- Testing
- Treatment
- Your situation
- Your wellbeing
- A-Z of ovarian cancer
- Clinical trials
- Know your Os
- Support for you
- Stories
-
Get involved
- Fundraise for us
- Events and challenges
- Campaign
- Raise awareness
- Volunteer
- Leave a gift in your will
- Play the On Target Lottery
- Remember someone special
- Trusts and foundations
- Philanthropy and major gifts
- Corporate and strategic partnerships
- Make a donation
- Give more for less
- Ovarian Cancer Awareness Month
- ROSELLA: A study of relacorilant in combination with nab-paclitaxel in platinum resistant ovarian cancer
- Support line
Sitemap
- News
- Health professionals
-
Research
-
Our research projects
- Effective and safe immunotherapy against low grade serous ovarian cancer
- Developing new treatments for low-grade serous ovarian cancer
- Finding new treatment approaches for drug-resistant ovarian cancer
- GTEOC study
- Targeting microtubules to overcome resistance to chemotherapy drugs
- Palliative chemotherapy to manage symptoms in women with recurrent ovarian cancer
- Our research strategy
- Our research policies
- For researchers
-
Our research projects
- About us
